St. John's Wort Additional Bioactive Components Identified by PharmaPrint
This article was originally published in The Tan Sheet
Executive Summary
PharmaPrint's bioassay system has identified four components of St. John's wort with disease-related bioactivity in addition to the historical standard of hypericin, Senior VP-R&D Michael Tempesta, PhD, told the National Institute of Environmental Health Sciences' conference on medicinal herbs in Raleigh, N.C. Sept. 23.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
People In Brief
Perrigo promotes in pricing, planning
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: